Commission Implementing Decision (EU) 2024/1283 of 13 May 2024 postponing the expiry date of the approval of cis-tricos-9-ene for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Official Journal EN of the European Union L series 2024/1283 15.5.2024 COMMISSION IMPLEMENTING DECISION (EU) 2024/1283 of 13 May 2024 postponing the expiry date of the approval of cis-tricos-9-ene for use in biocidal products of product- type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012concerning the making available on the market and use of biocidal products(1), and in particular Article 14(5) thereof, After consulting the Standing Committee on Biocidal Products,

Whereas:

(1) Cis-tricos-9-ene was included in Annex I to Directive 98/8/EC of the European Parliament and of the Council(2)as an active substance for use in biocidal products of product-type 19. Pursuant to Article 86 of Regulation (EU) No 528/2012, it is therefore considered approved under that Regulation subject to the conditions set out in Annex I to Directive 98/8/EC.

(2) The approval of cis-tricos-9-ene for use in biocidal products of product-type 19 (‘the approval’) is to expire on 30 September 2024. On 6 April 2023an application was submitted in accordance with Article 13(1) of Regulation

(EU) No 528/2012 for the renewal of the approval of cis-tricos-9-ene for use in biocidal products of product-type 19 (‘the application’).

(3) On 9 August 2023, the evaluating competent authority of Austria informed the Commission that it had decided, pursuant to Article 14(1) of Regulation (EU) No 528/2012, that a full evaluation of the application was necessary.

Pursuant to Article 8(1) of that Regulation, the evaluating competent authority is to perform a full evaluation of the application within 365 days of its validation.

(4) The evaluating competent authority may, as appropriate, require the applicant to provide sufficient data to carry out the evaluation, in accordance with Article 8(2) of Regulation (EU) No 528/2012. In that event, the 365-day period is suspended for a period that may not exceed 180 days in total unless a longer suspension is justified by the nature of the data requested or by exceptional circumstances.

(5) Within 270 days of receipt of a recommendation from the evaluating competent authority, the European Chemicals Agency (‘the Agency’) is to prepare and submit to the Commission an opinion on renewal of the approval of the active substance in accordance with Article 14(3) of Regulation (EU) No 528/2012.

(6) Consequently, for reasons beyond the control of the applicant, the approval is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to postpone the expiry date of the approval for a period of time sufficient to enable the examination of the application. Taking into account the time-limits for evaluation by the evaluating competent authority, for preparation and submission by the Agency of its opinion and the time needed for the Commission to decide whether to renew the approval of cis-tricos-9-ene for use in biocidal products of product-type 19, the expiry date should be postponed to 31 March 2027.

(1) OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528

(2) Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (OJ L 123, 24.4.1998, p. 1, ELI: http://data.europa.eu/eli/dir/1998/8).

ELI: http://data.europa.eu/eli/dec_impl/2024/1283/oj 1/2EN OJ L, 15.5.2024

(7) After the postponement of the expiry date of the approval, cis-tricos-9-ene remains approved for use in biocidal products of product-type 19 subject to the conditions set out in Annex I to Directive 98/8/EC,

HAS ADOPTED THIS DECISION:

Article 1 The expiry date of the approval of cis-tricos-9-ene for use in biocidal products of product-type 19 set out in Annex I to Directive 98/8/EC is postponed to 31 March 2027.

Article 2 This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Done at Brussels, 13 May 2024.

For the Commission The President Ursula VON DER LEYEN 2/2 ELI: http://data.europa.eu/eli/dec_impl/2024/1283/oj